Pooled surveillance testing for asymptomatic SARS-CoV-2 infections at a Veterinary Teaching Hospital College, University of Minnesota, December 2020–April 2021

Janice Mladonicky; Addisalem Bedada; Colin Yoder; Kimberly VanderWaal; Jerry Torrison; Scott J. Wells

doi:10.3389/fpubh.2022.879107

Pooled surveillance testing for asymptomatic SARS-CoV-2 infections at a Veterinary Teaching Hospital College, University of Minnesota, December 2020–April 2021

Janice Mladonicky, Addisalem Bedada, Colin Yoder, Kimberly VanderWaal, Jerry Torrison, Scott J. Wells

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

To evaluate the use of asymptomatic surveillance, we implemented a surveillance program for asymptomatic SARS-CoV-2 infection in a voluntary sample of individuals at the College of Veterinary Medicine at the University of Minnesota. Self-collected anterior nasal samples were tested using real time reverse transcription-polymerase chain reaction (RT-PCR), in a 5:1 pooled testing strategy, twice weekly for 18 weeks. Positive pools were deconvoluted into individual tests, revealing an observed prevalence of 0.07% (3/4,525). Pooled testing allowed for large scale testing with an estimated cost savings of 79.3% and modeling demonstrated this testing strategy prevented up to 2 workplace transmission events, averting up to 4 clinical cases. At the study endpoint, antibody testing revealed 80.7% of participants had detectable vaccine antibody levels while 9.6% of participants had detectable antibodies to natural infection.

Original language	English (US)
Article number	879107
Journal	Frontiers in Public Health
Volume	10
DOIs	https://doi.org/10.3389/fpubh.2022.879107
State	Published - Aug 5 2022

Bibliographical note

Funding Information:
Funding was provided by the University of Minnesota Medical School, Office of the Vice Dean for Research.

Funding Information:
The authors would like to acknowledge the students, staff, and faculty at the University of Minnesota who participated in this study; the veterinary student team who provided logistical support (McKayla Carlson, Grace Miller, Lindsay Miller, Kim Nguyen, Michael Streitz); Devi Patnayak and others at the University of Minnesota Veterinary Diagnostic Laboratory for providing laboratory support; the University of Minnesota Genomics Center and Quansys Biosciences for testing of samples; Jeff Bender, Sandra Godden, and Craig Hedberg for technical guidance and manuscript review; and the University of Minnesota Hospital Management Team for providing facility support.

Publisher Copyright:
Copyright © 2022 Mladonicky, Bedada, Yoder, VanderWaal, Torrison and Wells.

Keywords

COVID-19
SARS-CoV-2
cost effective
pooled testing
serology
surveillance
veterinary medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.3389/fpubh.2022.879107

Find It

Find It at U of M Libraries

Cite this

@article{09c482e1ee814d1f8ed3e6f793c899ee,

title = "Pooled surveillance testing for asymptomatic SARS-CoV-2 infections at a Veterinary Teaching Hospital College, University of Minnesota, December 2020–April 2021",

abstract = "To evaluate the use of asymptomatic surveillance, we implemented a surveillance program for asymptomatic SARS-CoV-2 infection in a voluntary sample of individuals at the College of Veterinary Medicine at the University of Minnesota. Self-collected anterior nasal samples were tested using real time reverse transcription-polymerase chain reaction (RT-PCR), in a 5:1 pooled testing strategy, twice weekly for 18 weeks. Positive pools were deconvoluted into individual tests, revealing an observed prevalence of 0.07% (3/4,525). Pooled testing allowed for large scale testing with an estimated cost savings of 79.3% and modeling demonstrated this testing strategy prevented up to 2 workplace transmission events, averting up to 4 clinical cases. At the study endpoint, antibody testing revealed 80.7% of participants had detectable vaccine antibody levels while 9.6% of participants had detectable antibodies to natural infection.",

keywords = "COVID-19, SARS-CoV-2, cost effective, pooled testing, serology, surveillance, veterinary medicine",

author = "Janice Mladonicky and Addisalem Bedada and Colin Yoder and Kimberly VanderWaal and Jerry Torrison and Wells, {Scott J.}",

note = "Funding Information: Funding was provided by the University of Minnesota Medical School, Office of the Vice Dean for Research. Funding Information: The authors would like to acknowledge the students, staff, and faculty at the University of Minnesota who participated in this study; the veterinary student team who provided logistical support (McKayla Carlson, Grace Miller, Lindsay Miller, Kim Nguyen, Michael Streitz); Devi Patnayak and others at the University of Minnesota Veterinary Diagnostic Laboratory for providing laboratory support; the University of Minnesota Genomics Center and Quansys Biosciences for testing of samples; Jeff Bender, Sandra Godden, and Craig Hedberg for technical guidance and manuscript review; and the University of Minnesota Hospital Management Team for providing facility support. Publisher Copyright: Copyright {\textcopyright} 2022 Mladonicky, Bedada, Yoder, VanderWaal, Torrison and Wells.",

year = "2022",

month = aug,

day = "5",

doi = "10.3389/fpubh.2022.879107",

language = "English (US)",

volume = "10",

journal = "Frontiers in Public Health",

issn = "2296-2565",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Pooled surveillance testing for asymptomatic SARS-CoV-2 infections at a Veterinary Teaching Hospital College, University of Minnesota, December 2020–April 2021

AU - Mladonicky, Janice

AU - Bedada, Addisalem

AU - Yoder, Colin

AU - VanderWaal, Kimberly

AU - Torrison, Jerry

AU - Wells, Scott J.

N1 - Funding Information: Funding was provided by the University of Minnesota Medical School, Office of the Vice Dean for Research. Funding Information: The authors would like to acknowledge the students, staff, and faculty at the University of Minnesota who participated in this study; the veterinary student team who provided logistical support (McKayla Carlson, Grace Miller, Lindsay Miller, Kim Nguyen, Michael Streitz); Devi Patnayak and others at the University of Minnesota Veterinary Diagnostic Laboratory for providing laboratory support; the University of Minnesota Genomics Center and Quansys Biosciences for testing of samples; Jeff Bender, Sandra Godden, and Craig Hedberg for technical guidance and manuscript review; and the University of Minnesota Hospital Management Team for providing facility support. Publisher Copyright: Copyright © 2022 Mladonicky, Bedada, Yoder, VanderWaal, Torrison and Wells.

PY - 2022/8/5

Y1 - 2022/8/5

N2 - To evaluate the use of asymptomatic surveillance, we implemented a surveillance program for asymptomatic SARS-CoV-2 infection in a voluntary sample of individuals at the College of Veterinary Medicine at the University of Minnesota. Self-collected anterior nasal samples were tested using real time reverse transcription-polymerase chain reaction (RT-PCR), in a 5:1 pooled testing strategy, twice weekly for 18 weeks. Positive pools were deconvoluted into individual tests, revealing an observed prevalence of 0.07% (3/4,525). Pooled testing allowed for large scale testing with an estimated cost savings of 79.3% and modeling demonstrated this testing strategy prevented up to 2 workplace transmission events, averting up to 4 clinical cases. At the study endpoint, antibody testing revealed 80.7% of participants had detectable vaccine antibody levels while 9.6% of participants had detectable antibodies to natural infection.

AB - To evaluate the use of asymptomatic surveillance, we implemented a surveillance program for asymptomatic SARS-CoV-2 infection in a voluntary sample of individuals at the College of Veterinary Medicine at the University of Minnesota. Self-collected anterior nasal samples were tested using real time reverse transcription-polymerase chain reaction (RT-PCR), in a 5:1 pooled testing strategy, twice weekly for 18 weeks. Positive pools were deconvoluted into individual tests, revealing an observed prevalence of 0.07% (3/4,525). Pooled testing allowed for large scale testing with an estimated cost savings of 79.3% and modeling demonstrated this testing strategy prevented up to 2 workplace transmission events, averting up to 4 clinical cases. At the study endpoint, antibody testing revealed 80.7% of participants had detectable vaccine antibody levels while 9.6% of participants had detectable antibodies to natural infection.

KW - COVID-19

KW - SARS-CoV-2

KW - cost effective

KW - pooled testing

KW - serology

KW - surveillance

KW - veterinary medicine

UR - http://www.scopus.com/inward/record.url?scp=85136506356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85136506356&partnerID=8YFLogxK

U2 - 10.3389/fpubh.2022.879107

DO - 10.3389/fpubh.2022.879107

M3 - Article

C2 - 35991058

AN - SCOPUS:85136506356

SN - 2296-2565

VL - 10

JO - Frontiers in Public Health

JF - Frontiers in Public Health

M1 - 879107

ER -

Pooled surveillance testing for asymptomatic SARS-CoV-2 infections at a Veterinary Teaching Hospital College, University of Minnesota, December 2020–April 2021

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this